Royal London Asset Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.3M | Hold |
|
|||||
|
2025
Q2 | $6.43M | Sell |
|
|||||
|
2025
Q1 | $5.65M | Buy |
|
|||||
|
2024
Q4 | $4.53M | Buy |
|
|||||
|
2024
Q3 | $4.53M | Buy |
|
|||||
|
2024
Q2 | $4.11M | Sell |
|
|||||
|
2024
Q1 | $10.3M | Buy |
|
|||||
|
2023
Q4 | $9.04M | Buy |
|
|||||
|
2023
Q3 | $8.65M | Buy |
|
|||||
|
2023
Q2 | $8.17M | Buy |
|
|||||
|
2023
Q1 | $5.13M | Buy |
|
|||||
|
2022
Q4 | $5.04M | Buy |
|
|||||
|
2022
Q3 | $4.82M | Sell |
|
|||||
|
2022
Q2 | $5.22M | Hold |
|
|||||
|
2022
Q1 | $4.83M | Buy |
|
|||||
|
2021
Q4 | $4.71M | Hold |
|
|||||
|
2021
Q3 | $4.27M | Hold |
|
|||||
|
2021
Q2 | $4.84M | Hold |
|
|||||
|
2021
Q1 | $5.15M | Buy |
|